neoplasm
• 27% of mice develop squamous cell carcinomas (SCCs) in the epidermis with more malignancy (increased aggressiveness and higher grade) compared to in Tg(KRT14-HPV16)wt1Dh mice
|
• mice exhibit fewer incidence of malignant conversions compared with Tg(KRT14-HPV16)wt1Dh mice
• 27% of mice develop squamous cell carcinomas (SCCs) in the epidermis compared to 50% of Tg(KRT14-HPV16)wt1Dh mice
• however, the numbers of SCCs per mouse is the same as in Tg(KRT14-HPV16)wt1Dh mice, and expression of the wild-type allele restores normal Tg(KRT14-HPV16)wt1Dh-induced neoplasia
|
integument
• compared to in Tg(KRT14-HPV16)wt1Dh mice
|
• at 2 months, all mice exhibit mild hyperplastic epidermis compared to in wild-type mice but not as severe as in Tg(KRT14-HPV16)wt1Dh mice
• at 4 months, 20% of mice develop epidermal dysplasia unlike in wild-type mice
• at 7 months, 90% of mice exhibit epidermal dysplasia unlike in wild-type mice
|
• 27% of mice develop squamous cell carcinomas (SCCs) in the epidermis with more malignancy (increased aggressiveness and higher grade) compared to in Tg(KRT14-HPV16)wt1Dh mice
|
cellular
• compared to in Tg(KRT14-HPV16)wt1Dh mice
|